Cargando…

Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis

BACKGROUND AND OBJECTIVES: Excessive activation of certain lipid mediator (LM) pathways plays a role in the complex pathogenesis of multiple sclerosis (MS). However, the relationship between bioactive LMs and different aspects of CNS-related pathophysiologic processes remains largely unknown. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broos, Jelle Y., Loonstra, Floor C., de Ruiter, Lodewijk R.J., Gouda, Mariam, Fung, Wing Hee, Schoonheim, Menno M., Heijink, Marieke, Strijbis, Eva M.M., Teunissen, Charlotte, Killestein, Joep, de Vries, Helga E., Giera, Martin, Uitdehaag, Bernard M.J., Kooij, Gijs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401685/ https://www.ncbi.nlm.nih.gov/pubmed/37290971 http://dx.doi.org/10.1212/WNL.0000000000207459

Ejemplares similares

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

Adipokines in multiple sclerosis patients are related to clinical and radiological measures
por: Loonstra, Floor C., et al.
Publicado: (2022)

The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort
por: Loonstra, Floor C., et al.
Publicado: (2023)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

Repair what is lost: Neuroprotection through neural stem cells in progressive MS
por: Schoonheim, Menno M., et al.
Publicado: (2023)

Infusion-related events during natalizumab: No need for post-infusion monitoring
por: Loonstra, Floor C, et al.
Publicado: (2019)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

Early-life stress and dietary fatty acids impact the brain lipid/oxylipin profile into adulthood, basally and in response to LPS
por: Reemst, Kitty, et al.
Publicado: (2022)

4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes
por: Strijbis, Eva MM, et al.
Publicado: (2020)

COVID-19 in multiple sclerosis: The Dutch experience
por: Loonstra, Floor C, et al.
Publicado: (2020)

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

State Changes During Resting-State (Magneto)encephalographic Studies: The Effect of Drowsiness on Spectral, Connectivity, and Network Analyses
por: Strijbis, Eva M. M., et al.
Publicado: (2022)

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients
por: Bridel, Claire, et al.
Publicado: (2018)

Plasma proteome in multiple sclerosis disease progression
por: Malekzadeh, Arjan, et al.
Publicado: (2019)

Natalizumab concentrations during pregnancy in three patients with multiple sclerosis
por: Toorop, Alyssa A, et al.
Publicado: (2021)

Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS
por: Schoonhoven, Deborah N, et al.
Publicado: (2018)

The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis
por: Coerver, Eline M. E., et al.
Publicado: (2022)

Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis
por: Simon, Shira, et al.
Publicado: (2023)

Personalized monitoring of ambulatory function with a smartphone 2-minute walk test in multiple sclerosis
por: Lam, Ka-Hoo, et al.
Publicado: (2023)

Smartphone‐derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis
por: Lam, Ka‐Hoo, et al.
Publicado: (2021)

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2022)

Gray matter networks and cognitive impairment in multiple sclerosis
por: Rimkus, Carolina M, et al.
Publicado: (2018)

Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosis
por: Nauta, Ilse M, et al.
Publicado: (2020)

Disease severity classification using passively collected smartphone-based keystroke dynamics within multiple sclerosis
por: Hoeijmakers, Aleide, et al.
Publicado: (2023)

A review on algae and plants as potential source of arachidonic acid
por: Shanab, Sanaa M.M., et al.
Publicado: (2018)

Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis
por: Lam, KH, et al.
Publicado: (2020)

Dietary Fish Oil Increases the Number of CD11b(+)CD27(−) NK Cells at the Inflammatory Site and Enhances Key Hallmarks of Resolution of Murine Antigen-Induced Peritonitis
por: Jensen, Kirstine Nolling, et al.
Publicado: (2022)

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment
por: Leurs, Cyra E, et al.
Publicado: (2017)

The sequence of structural, functional and cognitive changes in multiple sclerosis
por: Dekker, Iris, et al.
Publicado: (2020)

Blood platelet RNA enables the detection of multiple sclerosis
por: Sol, Nik, et al.
Publicado: (2020)

Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis
por: Balk, Lisanne J, et al.
Publicado: (2017)

Impaired saccadic eye movements in multiple sclerosis are related to altered functional connectivity of the oculomotor brain network
por: Nij Bijvank, J.A., et al.
Publicado: (2021)

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
por: Toorop, Alyssa A., et al.
Publicado: (2020)

gMS-Classifier1 does not predict disability progression in multiple sclerosis
por: van Rossum, Johannis A, et al.
Publicado: (2018)

The plasma peptides of Alzheimer’s disease
por: Florentinus-Mefailoski, Angelique, et al.
Publicado: (2021)

Serum neurofilament light chain predicts cognitive worsening in secondary progressive multiple sclerosis better than brain MRI measures
por: Gaetani, Lorenzo, et al.
Publicado: (2022)

Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study
por: Tewarie, Prejaas, et al.
Publicado: (2018)

Predicting clinical progression in multiple sclerosis after 6 and 12 years
por: Dekker, I., et al.
Publicado: (2019)

A novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage
por: Nij Bijvank, Jenny A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_90vb1e67ppcn9sl855hcvrorhm